Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) EV to EBITDA (2010 - 2026)

Lite Strategy (LITS) posted EV to EBITDA of 1.54 for Q1 2026, down 17.07% on a QoQ basis from 1.31 in Q4 2025, and down 172.22% year-over-year from 2.13 in Q1 2025.

Analysis

Lite Strategy (LITS) EV to EBITDA (2010 - 2026) Analysis & Trends

Lite Strategy has reported EV to EBITDA for 17 years, with the latest figure at 1.54 in Q1 2026.

  • On a quarterly basis, EV to EBITDA fell 172.22% year-over-year to 1.54 in Q1 2026; TTM through Mar 2026 was 0.57, a 424.96% decrease from a year earlier, with the FY2025 full-year figure at 0.09, up 106.83% from the prior year.
  • EV to EBITDA was 1.54 for Q1 2026 at Lite Strategy, down from 1.31 in the prior quarter.
  • The five-year high for EV to EBITDA was 11.53 in Q3 2022, with the low at 23.02 in Q4 2022.
  • Average EV to EBITDA over 5 years is 1.38, with a median of 2.13 recorded in 2025.
  • The largest YoY upside for EV to EBITDA was 751.18% in 2022 against a maximum downside of 10009.41% in 2022.
  • Over 5 years, EV to EBITDA stood at 23.02 in 2022, then jumped by 127.37% to 6.3 in 2023, then slumped by 66.2% to 2.13 in 2024, then plunged by 161.7% to 1.31 in 2025, then slipped by 17.07% to 1.54 in 2026.
  • The last three EV to EBITDA figures came in at 1.54 (Q1 2026), 1.31 (Q4 2025), and 16.37 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.54
Dec 31, 2025 -1.31
Sep 30, 2025 -16.37
Jun 30, 2025 0.54
Mar 31, 2025 2.13
Dec 31, 2024 2.13
Sep 30, 2024 3.34
Jun 30, 2024 1.00
Mar 31, 2024 8.56
Dec 31, 2023 6.30
Sep 30, 2023 -2.07
Jun 30, 2023 5.13
Mar 31, 2023 11.26
Dec 31, 2022 -23.02
Sep 30, 2022 11.53
Jun 30, 2022 4.45
Mar 31, 2022 11.46
Dec 31, 2021 0.23
Sep 30, 2021 -1.77
Jun 30, 2021 -1.46